A new cycloartane triterpenoid bisdesmoside, soulieoside S (1), was isolated from the ethanolic extract of rhizomes of Actaea vaginata. The structure was determined by extensive spectroscopic analysis including 1D-and 2D NMR and HRESIMS, as well as chemical methods. Compound 1 was evaluated for its cytotoxic activities against HepG2, MDA-MB231 and A549 cancer cell lines.
Actaea vaginata (Maxim.) J. Compton endemic to East Asia is the only species of the genus Souliea in the family Ranunculaceae, popularly used as traditional herb for the treatment of conjunctivitis and enteritis in China [1a] . Phytochemical studies disclosed cycloartane triterpenoid glycosides [1b,2,3]. Our previous research resulted in the isolation of three new cycloartane triterpene monoxylosides [4] . In the continuous course of our search for novel antitumor agents, one new cycloartane triterpenoid bisdesmoside, soulieoside S (1) was obtained from the rhizomes of A. vaginata.
The molecular formula of 1 was deduced as C 43 The HMBC experiment ( Figure 1 ) was performed to establish the location of the functional groups and the full structure of 1. The glucose residue was attached at C-25 due to the long-range [5] . NOEs were also detected between H 3 -30/H-16, H-17; H-3/H-5. The D-configuration of the xylose and glucose units was confirmed using GC-MS analysis after acidic hydrolysis of 1 following derivatization with L-cysteine methyl ester and silylation [6] . Therefore, the structure of compound 1 was established as (20S, 24S)-15α-acetoxy-16β,24;20,24-diepoxy-9,19cyclolanostane-3β, 25-diol-3-O-β-D-xylopyranosyl-25-O-β-D-glucopyranoside, and named soulieoside S, as illustrated in Figure 1 . Compound 1 was tested for its cytotoxicity against three human cancer cell lines using MTT assay. Compound 1 showed weak inhibitory effects with IC 50 values of 49.5−89.8 μM ( Table 2 ). 
Extraction and isolation:
The air-dried and powdered rhizomes of A. vaginata (1.5 kg) were with 95% ethanol (3 × 10 L) at room temperature. Removal of the ethanol under reduced pressure yielded the extract (135 g). The extract was suspended in distilled water and then the suspension was partitioned with EtOAc and n-BuOH, successively. The n-BuOH soluble fraction (49 g) was subjected to silica gel (100~200 mesh) column chromatography using a CH 2 Cl 2 -MeOH gradient (from 50:1 to 1:1) as eluent, to yield seven fractions (Fr. A-G). Fr. B (7.2 g) was applied to a silica gel (200~300 mesh) column eluting with CH 2 Cl 2 -MeOH gradient (from 25:1 to 5:1) to afford five fractions (Fr. B1-B5). Fr. B3 (1.8 g) was isolated by repeated over silica gel (300~400 mesh) eluting with CH 2 Cl 2 -MeOH (12:1-3:1) followed by thin layer chromatography preparation eluting with CH 2 Cl 2 -MeOH-Formic Acid (9:1:0.1) to yield 1 (5.8 mg).
Acid hydrolysis:
Compound 1 (1.5 mg) was heated in 2 mL of 2M trifluoroacetic acid at 95°C for 2 h, followed by usual workup [5c]. The presence of D-xylose and D-glucose was confirmed by comparison of its retention time with that of standard samples. 
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Cytotoxic assays:
The cytotoxicity of compound 1 was assessed against HepG2, A549, and MDA-MB231 human cancer cell lines by the MTT method as described earlier [5c].
Supplementary data: Spectral data for 1are available online.
